Home > Insider Trading > Filing (0001209191-10-058426)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339455	Somaxon Pharmaceuticals Inc.	SOMX	Pharmaceutical Preparations (2834)	200161599

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1024004	F David Hale	C/O Somaxon Pharmaceuticals, Inc. 3570 Carmel Mountain Road, Suite 100 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-11-02	8,050	$0.00	468,630	No	5	G	Indirect	By Hale Family Trust UTD 2/10/86
Common Stock	Disposition	2010-11-20	550	$0.00	468,080	No	5	G	Indirect	By Hale Family Trust UTD 2/10/86
Common Stock	Disposition	2010-12-01	107,893	$2.68	360,187	No	4	S	Indirect	By Hale Family Trust UTD 2/10/86

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Indirect	By Hale Family Trust UTD 2/10/86
No	5	G	Indirect	By Hale Family Trust UTD 2/10/86
No	4	S	Indirect	By Hale Family Trust UTD 2/10/86

Footnotes

This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, primarily to cover the taxes payable upon the vesting of 203,573 restricted stock units on December 1, 2010.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $2.64 to $2.73 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.